Non-Muscle-Invasive Bladder Cancer Clinical Trials Currently Running
Physician's Weekly,
BCG is the gold standard treatment for high-risk non-muscle-invasive bladder cancer (NMIBC) that may be managed without…
Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage
Overview of attention for article published in Current Urology Reports, November 2019
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (71st percentile)
Readers on
- mendeley
- 51 Mendeley